×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
MediciNova (NASDAQ:MNOV) investors are sitting on a loss of 89% if they invested five years ago
Yahoo Finance
Some stocks are best avoided. We don't wish catastrophic capital loss on anyone. Imagine if you held MediciNova, Inc...
2 days ago
MediciNova, Inc. (NASDAQ:MNOV) Short Interest Down 26.0% in April
MarketBeat
MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) was the target of a significant decrease in short interest during the month of April.
5 days ago
StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV)
Defense World
Stock analysts at StockNews.com assumed coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a research note issued on Monday...
3 days ago
MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the ...
GlobeNewswire
LA JOLLA, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...
1 month ago
We're Hopeful That MediciNova (NASDAQ:MNOV) Will Use Its Cash Wisely
Simply Wall St
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
2 weeks ago
MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted ...
Yahoo Finance
LA JOLLA, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...
1 month ago
MediciNova Vice President Geoffrey O'Brien Announces Retirement - TipRanks.com
Tipranks
Medicinova (MNOV) has shared an announcement. Geoffrey O'Brien will retire and step down from his role as Vice President at MediciNova, Inc.
1 month ago
MediciNova (NASDAQ:MNOV) Research Coverage Started at StockNews.com
MarketBeat
StockNews.com started coverage on shares of MediciNova in a research report on Monday. They set a "hold" rating for the company.
3 days ago
Type 2 Diabetes Market to Grow Rapidly, Predicts DelveInsight | Key Companies Active in the Domain - Eli Lilly and ...
PR Newswire
PRNewswire/ -- DelveInsight's Type 2 Diabetes Market Insights report includes a comprehensive understanding of current treatment practices,...
10 months ago
MediciNova Receives a New Patent Covering MN-001 for the Treatment of Scleroderma and Systemic Sclerosis in ...
GlobeNewswire
LA JOLLA, Calif., Aug. 15, 2023 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...
8 months ago